Previous 10 | Next 10 |
REDWOOD CITY, Calif. , Jan. 20, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Donald A. Middlebrook has been named Vice President, Cl...
Noteworthy events during the week of January 19 - 25 for healthcare investors. More news on: Epizyme, Inc., Nevro Corp., Generex Biotechnology Corporation, Healthcare stocks news, , Read more ...
Nevro (NYSE: NVRO ) announces preliminary Q4 and FY 2019 revenue and guidance for FY 2020. More news on: Nevro Corp., Healthcare stocks news, Read more ...
REDWOOD CITY, Calif. , Jan. 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its preliminary unaudited revenue for the fourth quarter and y...
REDWOOD CITY, Calif. , Jan. 10, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it will host and webcast an investor briefing at the Nort...
Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Amarin (NASDAQ: AMRN ) resumed with Neutral rating and $22 (5% upside) price target at JPMorgan. Shares down 2% premarket. More news on: Amarin Corporation plc, Glaukos Corporation, Galapagos NV, Healthcare stocks news, Stocks on the move, , Read more ...
Biotech, hands down, wins the race for out-performance in the healthcare sector. Delivering new, valuable medicines has proven to be a winning strategy, even if the growth in their stocks is based on the hope of future drugs. However, this list focuses on the top 10 healthcare stocks in 2019, n...
REDWOOD CITY, Calif. , Dec. 19, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro's Chairman, CEO and President,...
Mergers Three Days in a Row We are now well over $100 billion in the last six weeks in announced M&A. Talking heads still haven’t caught on that we are witnessing a significant acceleration in acquisitions. Peugeot Fiat Chrysler (FCAU) agrees to a $50 billion dollar deal, whi...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...